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Introduction
In recent years studies in vivo and in vitro have shown that vitamin D is able to influence biological responses that extend far beyond its classical effects on skeletal homeostasis.
Prominent amongst these extra-skeletal effects is the interaction between vitamin D and the immune system, including regulation of both innate and adaptive immune responses (Adams and Hewison 2008; Hewison 2011; Wei and Christakos 2015) . As a consequence of these observations, vitamin D-deficiency has been linked to increased risk of bacterial and viral infection (Lake and Adams 2011; Nnoaham and Clarke 2008) , as well as inflammatory and autoimmune disease (Cantorna 2012; Jeffery, et al. 2016) . The ability of supplementary or therapeutic vitamin D to prevent or improve these immune disorders is much less clear, and is the subject of randomized placebo control trials currently underway. Crucially, improved understanding of the mechanisms that underpin the immunomodulatory actions of vitamin D has greatly helped to improve the design and outcome of clinical trials. In particular, unbiased analysis of gene responses to vitamin D supplementation has uncovered previously unrecognised immune targets for vitamin D Liu, et al. 2006) that are now key markers of vitamin D function in supplementation trials.
The initial observation linking vitamin D and immune function was detection of the nuclear vitamin D receptor (VDR) in lymphocytic and myeloid cells (Bhalla, et al. 1983; Mangelsdorf, et al. 1984) , indicating that these cells are able to respond to the active form of vitamin D, 1,25(OH) 2 D which binds with VDR. Further studies showed that cells from innate immune system such as monocytes/macrophages (Kreutz, et al. 1993 ) and dendritic cells (DC) (Hewison, et al. 2003) are also able to synthesise 1,25(OH) 2 D from the inactive precursor 25-hydroxyvitamin D (25D), the main circulating form of vitamin D. As the principal effect of dietary vitamin D supplementation is to raise serum levels of 25D, the ability of monocytes 4 and DCs to convert 25D to 1,25(OH) 2 D provides a localised, autocrine, pathway by which enhanced 25D can influence both innate and adaptive immunity (Jeffery, et al. 2012; Liu et al. 2006 ). These observations placed monocytes and DCs at the centre of the immunomodulatory activity of vitamin D. Synthesis of 1,25(OH) 2 D by these cells has the potential to influence endogenous innate immune cell function in the form of enhanced antibacterial activity (Hewison 2011; Liu et al. 2006) , and/or modulated antigen presentation (Hewison et al. 2003; Jeffery et al. 2012) . Furthermore, 1,25(OH) 2 D generated by monocytes and/or DCs may also impact adaptive immune function by exert exogenous effects on T cells or B cells expressing VDR (Jeffery et al. 2012) . Despite this, our understanding of the broader impact of vitamin D on cells from the innate immune system such as monocytes, macrophages and DCs remains far from clear.
Recent genome-wide expression studies using a monocyte-derived DC model highlighted the potential role of pathways associated with glucose metabolism, the TCA cycle and oxidative phosphorylation in mediating the effects of 1,25(OH) 2 D in promoting a tolerogenic DC phenotype (Ferreira, et al. 2015) . The aim of the current study was to provide a broader analysis of monocyte/DC responses to 1,25(OH) 2 D using existing gene expression repositories for multiple models of innate immune function. A meta-analysis of various datasets has been performed using an integrative workflow of open-source bioinformatics tools in order to give a biological context to the genes that are significantly modulated by 1,25(OH) 2 D. Finally, a comparison between the immune cell types selected has been applied to highlight the common biological processes that are altered by vitamin D.
Materials & Methods
Workflow overview
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A workflow was developed that utilises and integrates gene expression data from public repositories and places them in a biological context. Supplemental Figure 1 illustrates step by step the different tools and methods used in the analysis workflow. The first procedure consisted of open and free modules in ArrayAnalysis to i) perform a data quality check, ii) normalize the raw transcriptomic data and iii) perform a statistical analysis to obtain the parameters that show gene expression changes. The processed datasets were then applied to PathVisio v. 3.2.4 software (Kutmon, et al. 2015; van Iersel, et al. 2008 ) in order to perform statistical analyses that highlight the biological processes significantly altered as a consequence of gene expression changes and to visualize them in pathway diagrams from the WikiPathways pathway repository downloaded January 2017 (Kutmon, et al. 2016 ).
Comparison of the pathways shown to be significantly altered between the different cell types using PathVisio and WikiPathways was also represented by heat maps diagrams. In another approach, genes shown to be regulated by 1,25(OH) 2 D in all three cell models were used to identify enriched biological processes by Gene Ontology (GO) analysis and the results were visualized in biological networks using ClueGO v 2.3.3 (Bindea, et al. 2009 ), an app of Cytoscape 3.4.0 (Smoot, et al. 2011) (Supplemental Figure 1) . This workflow is designed in a user friendly fashion that does not require programming skills. In order to reproduce this workflow, it is recommended to use the latest versions of designated software. Furthermore, it is also important that gene annotation database and pathways repositories used in the analysis are regularly updated.
Transcriptomic datasets
Publically available transcriptomic data sets for 1,25(OH) 2 D-treated monocytes and dendritic cells (DC) were selected from ArrayExpress (https://www.ebi.ac.uk/arrayexpress/, (Kolesnikov, et al. 2015) ) and Gene Expression Omnibus (GEO, http://ncbi.nlm.nih.gov/geo/, 6 (Barrett and Edgar 2006) ). Selection criteria were based on gene expression studies performed in human cells including monocytic cell lines, monocytes and monocyte-derived DCs treated with 1,25(OH) 2 D: THP-1 cells (GSE52819 (Verway, et al. 2013) ), dendritic cells (GSE13762 (Széles, et al. 2009) ) and human monocytes (GSE56490 (Ferreira et al. 2015) ).
The selection of the three studies was based on experimental design and quality control analysis of the raw data. In all studies data were derived from human immune cells treated with 1,25(OH) 2 D, or from control (vehicle-treated) cells (Supplemental Table 1 ). In addition to the three cell models outlined above, preliminary analyses were also carried out using other 1,25(OH) 2 D-treated cell data repositories: THP-1 cells (GSE60102 (Nurminen, et al. 2015) ) and human monocytes (GSE46268 (Wheelwright, et al. 2014) ). In addition the data for GSE13762 (Széles, et al. 2009 ) included both immature and mature DC, and both these models were include in the preliminary analysis. Finally, as a negative control, the preliminary pathway analysis included a 1,25(OH) 2 D-treated B cell dataset (GSE22523 (Lisse, et al. 2011) . Because of missing raw data, incomplete gene annotation, incompatibility with ArrayAnalysis, and non-monocyte origin, some data from the preliminary analysis were not included in the main analysis of this study, but relevant findings related to the data were addressed in Results.
Pre-processing raw data and statistical data analysis in ArrayAnalysis
Unprocessed transcriptomics data were collected from the repositories and processed using the on-line workflow of ArrayAnalysis performed in January 2017
(https://www.arrayanalysis.org (Eijssen, et al. 2013) ) to obtain quality control reports, normalized data and perform statistical analysis. The workflow uses an R script as a core module with functions from several Bioconductor libraries. Quality control showed that there was no need to exclude any samples in the three selected transcriptomic datasets (data not 7 shown). Depending on the microarray technology used the normalization algorithm was selected. RMA method was used to normalize GSE52819 (Verway et al. 2013 ) and GSE56490 (Ferreira et al. 2015) . GC-RMA method was applied to GSE13762 (Szeles et al. 2009 ). Statistical analysis of the normalized data to determine genes that are significantly altered (up/down-regulated), was carried out with a second module from ArrayAnalysis including the moderated t-test from the R/Bioconductor package limma (Ritchie, et al. 2009 ).
The output is a 
Pathway statistics and analysis in PathVisio
PathVisio v. 3.2.4 (Kutmon, et al. 2015; van Iersel, et al. 2008) , an open-source pathway creation and analysis tool, was used to contextualize significantly altered genes, and altered biological processes were visualised using the biological pathway repository WikiPathways (Kutmon, et al. 2016 genes measured (N), genes that satisfy the criterion (R), genes measured in the experiment that are present in the pathway (n) and genes in the pathway measured in the experiment that satisfy the criteria (r):
The Z-score is used to measure how significantly a subset of genes is altered in a certain pathway compared to the complete dataset. In our analysis, biological pathways that have a Z-score equal to or above 1.96 are considered significantly altered. The function heatmap.2 from the R library gplots (v.3.0.1) was used to create a heatmap that compared and hierarchically clustered pathways for each of the datasets based on Z-scores.
GO analysis with ClueGO in Cytoscape
GO analysis of the in common significantly altered genes (absolute log2FC >= 0.26 and adjusted p value < 0.05) in the three types of immune cells was performed to identify and visualize which GO biological process terms were significantly overrepresented. Within the commonly used open-source network analysis tool Cytoscape v. 3.4 (Smoot et al. 2011) , the ClueGO app v 2.3.3 performs GO analysis to group a set of genes in GO terms minimizing redundancy and display their relationship in a network. Connections between the GO nodes 9 containing a common sub-set of genes were calculated with kappa statistics based on the correlated genes that are grouped. 
Results
Differentially
GO analysis shows metabolic, immunological and apoptotic processes altered by 1,25D in THP-1 cells, dendritic cells and monocytes
ArrayAnalysis processing of GSE52819, GSE13762, GSE56490 datasets was carried out to define the number of genes measured and number of genes significantly regulated by 1,25(OH) 2 D in each of the three cell models ( Table 1) . Further analysis of these data showed that a total of 230 genes were significantly regulated by 1,25(OH) 2 D in all three cell models (Figure 2 ), and these genes were selected for subsequent GO analysis.
GO analysis using the list of 230 commonly altered genes was carried out using ClueGO in 
1,25(OH) 2 D and apoptosis
In the GO analysis, a network that relates apoptosis GO terms revealed three GO core groups: 1) negative regulation of apoptotic signaling; 2) intrinsic apoptotic signalling; 3) regulation of intrinsic apoptotic signaling pathway (Supplemental Figure 3B) . These groups include genes that were up-regulated by 1,25 ( 
Discussion
Bioinformatics, or applying informatics to study biology, seeks to provide an unbiased and statistically robust insight into the molecular mechanisms that impact human health and disease. Large-scale projects such as the Human Genome Project (Roberts, et al. 2001 ) and ENCODE (Consortium, et al. 2007 ) have provided access to expansive repositories of data that have greatly helped to shed light on genomic function. However, utilisation of these data repositories to answer specific biological questions remains limited. This is particularly true for studies of vitamin D, despite detailed genome-wide analysis of VDR-chromatin 15 interactions (Pike, et al. 2017) . In most cases, analysis of the genomic responses to 1,25(OH) 2 D-VDR complexes has been cell-specific, incorporating both classical calciotropic (Meyer, et al. 2014) , and extra-skeletal , and dendritic cell (Ferreira et al. 2015) models to identify previously unrecognized molecular targets for active 1,25(OH) 2 D, which have, in turn, revealed antibacterial (Adams, et al. 2009; Bacchetta, et al. 2014; Chun, et al. 2015) , and metabolic regulatory (Vanherwegen, et al. 2017) The most striking observation from the current analysis is that in all three cell models 1,25(OH) 2 D is strongly associated with changes in cellular metabolism, oxidative phosphorylation and energy generation. Oxidative phosphorylation has been shown to play an important role in promoting a tolerogenic phenotype in immune cells (Michalek, et al. 2011; Vats, et al. 2006) . Previous studies have reported effects of 1,25(OH) 2 D on mitochondrial functionality and physiology, and pathways related to glucose metabolism in monocyte-derived DCs (Ferreira et al. 2015) . In a similar fashion, serum 25(OH)D status has been linked to markers of bioenergetic pathways in human peripheral blood mononuclear cells (Calton, et al. 2016) , and active 1,25(OH) 2 D has been shown to increase production of ATP and ROS, as well as altering mitochondrial functionality and morphology by increasing its membrane potential and total mass of mitochondria in differentiating monocytes (Ferreira et al. 2015) . It was therefore notable in the current study that the most significantly altered pathways common to all three innate immune cell types were those associated with mitochondrial function: TCA cycle, electron transport chain and oxidative phosphorylation. . The datasets in this particular study did 19 not conform to requirements for the comparative pathway analysis used in our current study.
However, we were able to carry out a preliminary pathway analysis of these data (Supplemental Figure 7) . Here it was notable that metabolic and cell cycle effects of 1,25(OH) 2 D were only observed after 24 hours of treatment, suggesting that pathway regulation by vitamin D is highly time-dependent.
The third major group of pathways shown to be regulated by 1,25(OH) 2 D in THP-1, monocytes and DCs were those associated with programmed cell death (apoptosis).
Previous studies have reported pro-apoptotic effects of 1,25(OH) 2 D in primary cultures of monocytes, with this effect being mediated via interference with CD40 responses (Almerighi, et al. 2009 ). Conversely, in the HL-60 leukemic cell line 1,25(OH) 2 D was reported to promote resistance to apoptosis (Mosieniak, et al. 2006) . Furthermore, studies from our group have shown that antisense knockdown of VDR in another leukemic cell line, U937, promoted cell apoptosis (Hewison, et al. 1996) . Data from the current study further support a role for 1,25(OH) 2 D in regulating apoptosis of innate immune cells: common genes in the three datasets compared are commonly up-regulated (TNFTSF10D) and down-regulated (caspases family proteins and APAF1).
Conclusions
Understanding the entire set of results of high-throughput gene expression studies has often been challenging, caused by the complicated process of data analysis, and the limited biological interpretation that could be extracted from the large datasets generated through bench experiments. As a consequence, genome-wide analyses have tended to focus on changes in expression for specific genes Liu et al. 2006 ), or small groups of genes associated with a specific pathway (Ferreira et al. 2015) . Supplemental Figure 1 . Overview of the analytical tools included in the workflow. Raw data were normalised and statistically analysed using ArrayAnalysis. Pathway analysis of normalised data was then carried out using PathVisio and WikiPathways. Commonly altered genes in different cell models were also analysed by gene ontology using Cytoscape and ClueGO. (GSE27270)) and an RNA-seq study where THP-1 cells were treated with 1,25(OH) 2 D for 2.5, 4 and 24 hours (Seuter et al. (GSE36323) 
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